MEPs urged for more clarity on vaccines and pace of immunisation

On TESSy, EU countries will report twice a week the number of vaccines received and jabs made

More clarity and transparency regarding vaccine contracts and the decision-making process at EU level is needed, said on Tuesday, MEPs from the Committee on Environment, Public Health and Food Safety. They discussed with Sandra Gallina, EU’s lead negotiator on Covid-19 vaccine contracts, about the state of play concerning the contracts, authorisations, availability and deployment, among others jab-related topics.

They asked Gallina on possible additional national or bilateral contracts. The EU executive confirmed that it is not aware of any such alleged contracts, saying that through the joint procurement agreement, the EU has priority to deliver vaccines, which will then be distributed to Member States on a pro-rata basis.

Answering to the questions about how many Europeans have already been vaccinated, Gallina stressed that as of next week, a dedicated platform will be available through the ECDC, so called European Surveillance System TESSy, where Member States can report, twice a week, the number of vaccines received and vaccinations took place.

The Commission specified that a reading room is open for MEPs wishing to review vaccine contracts, however only CureVac contract is currently available as for others is released pending the agreement of pharmaceutical companies.

Sandra Gallina also told lawmakers that the European Medicines Agency just received the application for the AstraZeneca vaccine and that the conditional market authorisation is expected at the end of January.

According to her the largest quantities of vaccines are expected from April onwards, as already agreed in the existing contracts - specific strategies for deployment, including priority groups for vaccination, are set up by each EU country.

Similar articles